<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01694212</url>
  </required_header>
  <id_info>
    <org_study_id>MZJ-2106</org_study_id>
    <nct_id>NCT01694212</nct_id>
  </id_info>
  <brief_title>Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy</brief_title>
  <official_title>Effect of Perioperative Topical Diclofenac on Intraocular Inflammation After Cataract Surgery and the Incidence of Postoperative Macular Edema in Patients With Diabetic Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Clinic Medic Zuljan Jukic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Hospital Center, Split</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Eye Clinic Medic Zuljan Jukic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes has many negative effects on patients' general health. Among many other consequences
      it speeds up the cataract formation and that is why diabetic patients need cataract surgery
      very often. The known side effect of cataract surgery even in otherwise healthy patients is
      postoperative edema of the back of the eye (what causes decrease of vision), which has
      greater incidence especially in patients who have diabetic eye problems. The cause of that
      might be the intraocular inflammation which was previously demonstrated to be significantly
      more prominent in patients with untreated diabetic eye problems. Therefore we will examine if
      the 7 day use of anti-inflammatory eye drops prior to the cataract surgery prevent the
      formation of the edema of the back of the eye.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Central Macular Thickness</measure>
    <time_frame>-7, 0, 1, 7, 30, 90 days after the cataract surger</time_frame>
    <description>The central macular thickness will be measured with OCT machine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>progression of diabetic retinopathy</measure>
    <time_frame>-7 and 90 days after cataract surgery</time_frame>
    <description>The grade of diabetic retinopathy will be assessed on fundus photographies according to ETDRS criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-12 concentration</measure>
    <time_frame>immediately before cataract surgery</time_frame>
    <description>The IL-12 concentration will be measured in the sample of humour aqueous taken at the beginning of cataract surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Macular Edema</condition>
  <condition>Cataract</condition>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Diclofenac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with diabetic retinopathy having preoperative treatment with diclofenac</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group having placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perioperative Diclofenac eye-drops administration</intervention_name>
    <arm_group_label>Diclofenac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of nonproliferative diabetic retinopathy

          -  presence of the cataract (LOCS 2-3)

        Exclusion Criteria:

          -  other chronic or acute eye diseases

          -  hypersensitivity to any component of the diclofenac eye-drops patients on oral
             anticoagulant therapy

          -  allergy to salycilates
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ljubo Znaor, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Center, Split</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Poliklinika Medic Zuljan JukiÄ‡</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2012</study_first_submitted>
  <study_first_submitted_qc>September 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2012</study_first_posted>
  <last_update_submitted>April 19, 2017</last_update_submitted>
  <last_update_submitted_qc>April 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Center, Split</investigator_affiliation>
    <investigator_full_name>Ljubo Znaor</investigator_full_name>
    <investigator_title>Ophthalmologist</investigator_title>
  </responsible_party>
  <keyword>Macular edema</keyword>
  <keyword>Cataract</keyword>
  <keyword>Diabetic retinopathy</keyword>
  <keyword>Anti-inflammatory agents,Non-steroidal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

